These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1482710)

  • 1. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic therapy targeting metastatic melanoma: allovectin-7.
    Chowdhery R; Gonzalez R
    Immunotherapy; 2011 Jan; 3(1):17-21. PubMed ID: 21174553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
    Hersh EM; Akporiaye E; Harris D; Stopeck AT; Unger EC; Warneke JA; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1371-84. PubMed ID: 7893808
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer.
    Rubin J; Charboneau JW; Reading C; Kovach JS
    Hum Gene Ther; 1994 Nov; 5(11):1385-99. PubMed ID: 7893809
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions.
    Vogelzang NJ; Lestingi TM; Sudakoff G; Kradjian SA
    Hum Gene Ther; 1994 Nov; 5(11):1357-70. PubMed ID: 7893807
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy of malignancy by in vivo gene transfer into tumors.
    Hum Gene Ther; 1992 Aug; 3(4):399-410. PubMed ID: 1525212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for cancer by direct gene transfer into tumors.
    Nabel GJ; Chang AE; Nabel EG; Plautz GE; Ensminger W; Fox BA; Felgner P; Shu S; Cho K
    Hum Gene Ther; 1994 Jan; 5(1):57-77. PubMed ID: 8155772
    [No Abstract]   [Full Text] [Related]  

  • 9. Allovectin-7 therapy in metastatic melanoma.
    Bedikian AY; Del Vecchio M
    Expert Opin Biol Ther; 2008 Jun; 8(6):839-44. PubMed ID: 18476795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct gene transfer for treatment of human cancer.
    Nabel GJ; Yang ZY; Nabel EG; Bishop K; Marquet M; Felgner PL; Gordon D; Chang AE
    Ann N Y Acad Sci; 1995 Nov; 772():227-31. PubMed ID: 8546397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule.
    DeBruyne L
    Cancer Immunol Immunother; 1996 Nov; 43(3):180-9. PubMed ID: 9001572
    [No Abstract]   [Full Text] [Related]  

  • 13. Velimogene aliplasmid.
    Soares HP; Lutzky J
    Expert Opin Biol Ther; 2010 May; 10(5):841-51. PubMed ID: 20367461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma.
    Nabel EG; Yang Z; Muller D; Chang AE; Gao X; Huang L; Cho KJ; Nabel GJ
    Hum Gene Ther; 1994 Sep; 5(9):1089-94. PubMed ID: 7833368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
    Norman JA; Parker S; Lew D; Manthorpe M; Marquet M
    Hum Gene Ther; 1995 May; 6(5):549-50. PubMed ID: 7578391
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular genetic interventions for cancer.
    Nabel GJ; Nabel EG; Yang Z; Fox BA; Plautz GE; Gao X; Huang L; Shu S; Gordon D; Chang AE
    Cold Spring Harb Symp Quant Biol; 1994; 59():699-707. PubMed ID: 7587133
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization.
    Grumet FC; Krishnaswamy S; See-Tho K; Filvaroff E; Hiraki DD
    Hum Immunol; 1994 Jul; 40(3):228-34. PubMed ID: 7960967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.
    Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA
    J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-induced hyporesponsiveness to paternal alloantigens. I. Alterations of humoral immunity in primiparous female rats.
    Head JR
    Transplantation; 1982 Nov; 34(5):251-7. PubMed ID: 6760481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.